ES2515240T3 - Derivados de 1H-pirazolo[4,3-c]isoquinoleínas, su preparación y su aplicación en terapéutica - Google Patents
Derivados de 1H-pirazolo[4,3-c]isoquinoleínas, su preparación y su aplicación en terapéutica Download PDFInfo
- Publication number
- ES2515240T3 ES2515240T3 ES10723723.2T ES10723723T ES2515240T3 ES 2515240 T3 ES2515240 T3 ES 2515240T3 ES 10723723 T ES10723723 T ES 10723723T ES 2515240 T3 ES2515240 T3 ES 2515240T3
- Authority
- ES
- Spain
- Prior art keywords
- pyrazolo
- difluorophenyl
- group
- isoquinoline
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 9
- YMYHYKRSWYKSJM-UHFFFAOYSA-N 1h-pyrazolo[4,3-c]isoquinoline Chemical class N1=CC2=CC=CC=C2C2=C1C=NN2 YMYHYKRSWYKSJM-UHFFFAOYSA-N 0.000 title description 8
- 230000001225 therapeutic effect Effects 0.000 title description 2
- -1 fluoroalkyl (C1-C4) Chemical group 0.000 claims abstract description 171
- 150000001875 compounds Chemical class 0.000 claims abstract description 62
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 29
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 28
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims abstract description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 9
- 239000001257 hydrogen Substances 0.000 claims abstract description 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 7
- 125000005843 halogen group Chemical group 0.000 claims abstract description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 67
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims description 51
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 37
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 21
- 125000006239 protecting group Chemical group 0.000 claims description 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 12
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 10
- 238000005859 coupling reaction Methods 0.000 claims description 9
- 125000006125 ethylsulfonyl group Chemical group 0.000 claims description 8
- 230000008878 coupling Effects 0.000 claims description 7
- 238000010168 coupling process Methods 0.000 claims description 7
- 229910052731 fluorine Chemical group 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 5
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 5
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims description 5
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- SEDZOYHHAIAQIW-UHFFFAOYSA-N trimethylsilyl azide Chemical compound C[Si](C)(C)N=[N+]=[N-] SEDZOYHHAIAQIW-UHFFFAOYSA-N 0.000 claims description 4
- NQJCBCPYVOOEHU-UHFFFAOYSA-N 3-[(1-cyclopropylsulfonylpiperidin-4-yl)amino]-5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound C1=2N=C(C=3C(=CC=CC=3F)F)C3=CC(C(=O)N)=CC=C3C=2NN=C1NC(CC1)CCN1S(=O)(=O)C1CC1 NQJCBCPYVOOEHU-UHFFFAOYSA-N 0.000 claims description 3
- KAMIUDBIEZUGRD-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NNC(C2=CC=C(C=C22)C#N)=C1N=C2C1=C(F)C=CC=C1F KAMIUDBIEZUGRD-UHFFFAOYSA-N 0.000 claims description 3
- POXMAXYPOXUVSC-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-ethynyl-n-(1-methylsulfonylpiperidin-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C#C)=C1N=C2C1=C(F)C=CC=C1F POXMAXYPOXUVSC-UHFFFAOYSA-N 0.000 claims description 3
- CFVDITVGKOGSEN-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-fluoro-n-(1-methylsulfonylpiperidin-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(F)C=C22)=C1N=C2C1=C(F)C=CC=C1F CFVDITVGKOGSEN-UHFFFAOYSA-N 0.000 claims description 3
- STJJDNLONRBDPP-UHFFFAOYSA-N N-[[5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1H-pyrazolo[4,3-c]isoquinolin-7-yl]methylidene]hydroxylamine Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NNC(C2=CC=C(C=NO)C=C22)=C1N=C2C1=C(F)C=CC=C1F STJJDNLONRBDPP-UHFFFAOYSA-N 0.000 claims description 3
- 229910017912 NH2OH Inorganic materials 0.000 claims description 3
- ZGSDJMADBJCNPN-UHFFFAOYSA-N [S-][NH3+] Chemical compound [S-][NH3+] ZGSDJMADBJCNPN-UHFFFAOYSA-N 0.000 claims description 3
- 239000007806 chemical reaction intermediate Substances 0.000 claims description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- FLKRMXAWABTWSH-UHFFFAOYSA-N piperidine-1-sulfonamide Chemical compound NS(=O)(=O)N1CCCCC1 FLKRMXAWABTWSH-UHFFFAOYSA-N 0.000 claims description 3
- KGRMVLZLUGWXOJ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NNC(C2=CC=C(C=O)C=C22)=C1N=C2C1=C(F)C=CC=C1F KGRMVLZLUGWXOJ-UHFFFAOYSA-N 0.000 claims description 2
- HDPQMXVWWMHIPF-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NNC(C2=CC=C(C=C22)C(N)=O)=C1N=C2C1=C(F)C=CC=C1F HDPQMXVWWMHIPF-UHFFFAOYSA-N 0.000 claims description 2
- HVIJNAFSDFOABE-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=O)C=C22)=C1N=C2C1=C(F)C=CC=C1F HVIJNAFSDFOABE-UHFFFAOYSA-N 0.000 claims description 2
- DGCKNPDFYYUIFV-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carbothioamide Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C(N)=S)=C1N=C2C1=C(F)C=CC=C1F DGCKNPDFYYUIFV-UHFFFAOYSA-N 0.000 claims description 2
- NTUDVKOTCJWOGK-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C(N)=O)=C1N=C2C1=C(F)C=CC=C1F NTUDVKOTCJWOGK-UHFFFAOYSA-N 0.000 claims description 2
- YOUTXQDWEMQOAE-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-sulfamoylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound C=12N=C(C=3C(=CC=CC=3F)F)C3=CC(C(=O)N)=CC=C3C2=NNC=1NC1CCN(S(N)(=O)=O)CC1 YOUTXQDWEMQOAE-UHFFFAOYSA-N 0.000 claims description 2
- ANAJNNLDOVJWNJ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-N'-hydroxy-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1H-pyrazolo[4,3-c]isoquinoline-7-carboximidamide Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C(=N)NO)=C1N=C2C1=C(F)C=CC=C1F ANAJNNLDOVJWNJ-UHFFFAOYSA-N 0.000 claims description 2
- STCPUAMYUVSVEY-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-n-(1-methylsulfonylpiperidin-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=CC=C22)=C1N=C2C1=C(F)C=CC=C1F STCPUAMYUVSVEY-UHFFFAOYSA-N 0.000 claims description 2
- 230000001093 anti-cancer Effects 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 238000006352 cycloaddition reaction Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 2
- DSJVZAMEIDDNFJ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[[1-(trifluoromethylsulfonyl)piperidin-4-yl]amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound C1=2N=C(C=3C(=CC=CC=3F)F)C3=CC(C(=O)N)=CC=C3C=2NN=C1NC1CCN(S(=O)(=O)C(F)(F)F)CC1 DSJVZAMEIDDNFJ-UHFFFAOYSA-N 0.000 claims 1
- HEUWEXGAILEABO-UHFFFAOYSA-N N-[[5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1H-pyrazolo[4,3-c]isoquinolin-7-yl]methylidene]hydroxylamine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=NO)C=C22)=C1N=C2C1=C(F)C=CC=C1F HEUWEXGAILEABO-UHFFFAOYSA-N 0.000 claims 1
- 150000001412 amines Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 223
- 239000000203 mixture Substances 0.000 description 209
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 192
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 168
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 157
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 150
- 239000007787 solid Substances 0.000 description 125
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 96
- 235000019341 magnesium sulphate Nutrition 0.000 description 96
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 84
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 78
- 229910052786 argon Inorganic materials 0.000 description 75
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 71
- 239000000243 solution Substances 0.000 description 70
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 69
- 239000000741 silica gel Substances 0.000 description 69
- 229910002027 silica gel Inorganic materials 0.000 description 69
- 238000003818 flash chromatography Methods 0.000 description 59
- 238000003760 magnetic stirring Methods 0.000 description 57
- 238000001228 spectrum Methods 0.000 description 51
- 238000001816 cooling Methods 0.000 description 47
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 42
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 40
- 239000007864 aqueous solution Substances 0.000 description 39
- 238000005481 NMR spectroscopy Methods 0.000 description 37
- 238000000105 evaporative light scattering detection Methods 0.000 description 35
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 34
- 238000005160 1H NMR spectroscopy Methods 0.000 description 30
- 239000012074 organic phase Substances 0.000 description 29
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 26
- 238000010992 reflux Methods 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 24
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 22
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 21
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 19
- 229910021529 ammonia Inorganic materials 0.000 description 18
- 230000005587 bubbling Effects 0.000 description 18
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 18
- 229910000024 caesium carbonate Inorganic materials 0.000 description 17
- 239000008346 aqueous phase Substances 0.000 description 16
- 239000000284 extract Substances 0.000 description 16
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 16
- 229920006395 saturated elastomer Polymers 0.000 description 16
- 238000003756 stirring Methods 0.000 description 16
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000012043 crude product Substances 0.000 description 15
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 239000006071 cream Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 12
- 239000012429 reaction media Substances 0.000 description 12
- 239000011780 sodium chloride Substances 0.000 description 12
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 11
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 229910052794 bromium Inorganic materials 0.000 description 10
- 238000004587 chromatography analysis Methods 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- FLQSRSQNICPZIH-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-amine Chemical compound CS(=O)(=O)N1CCC(N)CC1 FLQSRSQNICPZIH-UHFFFAOYSA-N 0.000 description 8
- BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 8
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 8
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 8
- 239000005457 ice water Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 8
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 6
- 235000005979 Citrus limon Nutrition 0.000 description 6
- 244000131522 Citrus pyriformis Species 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- QUFUUBBLCOBJPH-UHFFFAOYSA-N isoquinoline-7-carboxylic acid Chemical compound C1=CN=CC2=CC(C(=O)O)=CC=C21 QUFUUBBLCOBJPH-UHFFFAOYSA-N 0.000 description 6
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 6
- BWKAYBPLDRWMCJ-UHFFFAOYSA-N 1,1-diethoxy-n,n-dimethylmethanamine Chemical compound CCOC(N(C)C)OCC BWKAYBPLDRWMCJ-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 4
- IQFYYKKMVGJFEH-OYDXRQHMSA-N 1-[(2r,4s,5s)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H]([14CH2]O)[C@@H](O)C1 IQFYYKKMVGJFEH-OYDXRQHMSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000010511 deprotection reaction Methods 0.000 description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 229940124530 sulfonamide Drugs 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 4
- PCJDRCGDIIPPST-UHFFFAOYSA-N 1-ethylsulfonylpiperidin-4-amine Chemical compound CCS(=O)(=O)N1CCC(N)CC1 PCJDRCGDIIPPST-UHFFFAOYSA-N 0.000 description 3
- XTFDVTPMTAMGJT-UHFFFAOYSA-N 2,6-difluoro-n-[5-(4-fluorophenyl)-1h-pyrazol-4-yl]benzamide Chemical compound C1=CC(F)=CC=C1C1=C(NC(=O)C=2C(=CC=CC=2F)F)C=NN1 XTFDVTPMTAMGJT-UHFFFAOYSA-N 0.000 description 3
- ZYNOJKZMWJTNPF-UHFFFAOYSA-N 2,6-difluoro-n-[5-(4-iodophenyl)-1h-pyrazol-4-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=C(C=2C=CC(I)=CC=2)NN=C1 ZYNOJKZMWJTNPF-UHFFFAOYSA-N 0.000 description 3
- QRHUZEVERIHEPT-UHFFFAOYSA-N 2,6-difluorobenzoyl chloride Chemical compound FC1=CC=CC(F)=C1C(Cl)=O QRHUZEVERIHEPT-UHFFFAOYSA-N 0.000 description 3
- FSIBMLJFLPWMTD-UHFFFAOYSA-N 2-bromo-1-(4-iodophenyl)ethanone Chemical compound BrCC(=O)C1=CC=C(I)C=C1 FSIBMLJFLPWMTD-UHFFFAOYSA-N 0.000 description 3
- MRAXBEFITWCVBN-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NN(COCC[Si](C)(C)C)C(C2=CC=C(C=C22)C#N)=C1N=C2C1=C(F)C=CC=C1F MRAXBEFITWCVBN-UHFFFAOYSA-N 0.000 description 3
- OLCISFNJBPZYCZ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound C12=NC(C=3C(=CC=CC=3F)F)=C3C=C(C=O)C=CC3=C2N(COCC[Si](C)(C)C)N=C1NC1CCN(S(C)(=O)=O)CC1 OLCISFNJBPZYCZ-UHFFFAOYSA-N 0.000 description 3
- CXLJFHHREDVWFH-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound C12=NC(C=3C(=CC=CC=3F)F)=C3C=C(C#N)C=CC3=C2N(COCC[Si](C)(C)C)N=C1NC1CCN(S(C)(=O)=O)CC1 CXLJFHHREDVWFH-UHFFFAOYSA-N 0.000 description 3
- GUQZRLYVVFIRHR-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C#N)=C1N=C2C1=C(F)C=CC=C1F GUQZRLYVVFIRHR-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 3
- 150000001299 aldehydes Chemical group 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000031709 bromination Effects 0.000 description 3
- 238000005893 bromination reaction Methods 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 125000004212 difluorophenyl group Chemical group 0.000 description 3
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 3
- QEAGQILEKLFCEK-UHFFFAOYSA-N isoquinoline-7-carbaldehyde Chemical compound C1=CN=CC2=CC(C=O)=CC=C21 QEAGQILEKLFCEK-UHFFFAOYSA-N 0.000 description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 3
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 3
- 150000003456 sulfonamides Chemical class 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- JIADEIQNXDFOGT-UHFFFAOYSA-N 2,6-difluoro-n-(5-phenyl-1h-pyrazol-4-yl)benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=C(C=2C=CC=CC=2)NN=C1 JIADEIQNXDFOGT-UHFFFAOYSA-N 0.000 description 2
- KJGRSUULHMUPCR-UHFFFAOYSA-N 2-[2-(4-fluorophenyl)-2-oxoethyl]isoindole-1,3-dione Chemical compound C1=CC(F)=CC=C1C(=O)CN1C(=O)C2=CC=CC=C2C1=O KJGRSUULHMUPCR-UHFFFAOYSA-N 0.000 description 2
- YZQXQFWDJONQBS-UHFFFAOYSA-N 2-[2-(4-iodophenyl)-2-oxoethyl]isoindole-1,3-dione Chemical compound C1=CC(I)=CC=C1C(=O)CN1C(=O)C2=CC=CC=C2C1=O YZQXQFWDJONQBS-UHFFFAOYSA-N 0.000 description 2
- BPJVFQZFYUHERT-UHFFFAOYSA-N 2-[[3-bromo-5-(2,6-difluorophenyl)-7-ethenylpyrazolo[4,3-c]isoquinolin-2-yl]methoxy]ethyl-trimethylsilane Chemical compound BrC=1N(COCC[Si](C)(C)C)N=C(C2=CC=C(C=C)C=C22)C=1N=C2C1=C(F)C=CC=C1F BPJVFQZFYUHERT-UHFFFAOYSA-N 0.000 description 2
- IJBGDEFHSQBFSG-UHFFFAOYSA-N 3-[(1-cyclopropylsulfonylpiperidin-4-yl)amino]-5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound FC1=CC=CC(F)=C1C(C1=CC(=CC=C11)C#N)=NC2=C1NN=C2NC1CCN(S(=O)(=O)C2CC2)CC1 IJBGDEFHSQBFSG-UHFFFAOYSA-N 0.000 description 2
- AWJKWSNEKWBSAR-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound C=12C=C(C#N)C=CC2=C2N(COCC[Si](C)(C)C)N=C(Br)C2=NC=1C1=C(F)C=CC=C1F AWJKWSNEKWBSAR-UHFFFAOYSA-N 0.000 description 2
- FUYGOVWXELVQQF-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carboxylic acid Chemical compound C=12C=C(C(O)=O)C=CC2=C2N(COCC[Si](C)(C)C)N=C(Br)C2=NC=1C1=C(F)C=CC=C1F FUYGOVWXELVQQF-UHFFFAOYSA-N 0.000 description 2
- KBNWHGXGDFWFEW-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-2h-pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound FC1=CC=CC(F)=C1C(C1=CC(C=O)=CC=C11)=NC2=C1NN=C2Br KBNWHGXGDFWFEW-UHFFFAOYSA-N 0.000 description 2
- GZFMOLQHCGDVDV-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinoline Chemical compound FC1=CC=CC(F)=C1C(C1=CC=CC=C11)=NC2=C1NN=C2 GZFMOLQHCGDVDV-UHFFFAOYSA-N 0.000 description 2
- RXDWSFDULBSFOF-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound FC1=CC=CC(F)=C1C(C1=CC(=CC=C11)C#N)=NC2=C1NN=C2 RXDWSFDULBSFOF-UHFFFAOYSA-N 0.000 description 2
- UJNYFTCTSACTCY-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NN(COCC[Si](C)(C)C)C(C2=CC=C(C=O)C=C22)=C1N=C2C1=C(F)C=CC=C1F UJNYFTCTSACTCY-UHFFFAOYSA-N 0.000 description 2
- MVHBQZBUDGIBFV-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-ethenyl-n,n-dimethylpyrazolo[4,3-c]isoquinoline-1-sulfonamide Chemical compound C=12C=C(C=C)C=CC2=C2N(S(=O)(=O)N(C)C)N=CC2=NC=1C1=C(F)C=CC=C1F MVHBQZBUDGIBFV-UHFFFAOYSA-N 0.000 description 2
- JEQFXIVSJGPTBW-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-ethenyl-n-(1-methylsulfonylpiperidin-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C)C=C22)=C1N=C2C1=C(F)C=CC=C1F JEQFXIVSJGPTBW-UHFFFAOYSA-N 0.000 description 2
- CRKXOGRTOAAUBS-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-ethynyl-n-(1-methylsulfonylpiperidin-4-yl)-2-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(C)(=O)=O)CCC1NC=1N(COCC[Si](C)(C)C)N=C(C2=CC=C(C=C22)C#C)C=1N=C2C1=C(F)C=CC=C1F CRKXOGRTOAAUBS-UHFFFAOYSA-N 0.000 description 2
- TWJDPEKDMGZDPN-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-fluoro-n-(1-methylsulfonylpiperidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C12=NC(C=3C(=CC=CC=3F)F)=C3C=C(F)C=CC3=C2N(COCC[Si](C)(C)C)N=C1NC1CCN(S(C)(=O)=O)CC1 TWJDPEKDMGZDPN-UHFFFAOYSA-N 0.000 description 2
- JJLAATZLOUWPOB-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-iodo-1h-pyrazolo[4,3-c]isoquinoline Chemical compound FC1=CC=CC(F)=C1C(C1=CC(I)=CC=C11)=NC2=C1NN=C2 JJLAATZLOUWPOB-UHFFFAOYSA-N 0.000 description 2
- KSRSZVPLYYOTLU-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-n-(1-methylsulfonylpiperidin-4-yl)-2-(2-trimethylsilylethoxymethyl)-7-(2-trimethylsilylethynyl)pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(C)(=O)=O)CCC1NC=1N(COCC[Si](C)(C)C)N=C(C2=CC=C(C=C22)C#C[Si](C)(C)C)C=1N=C2C1=C(F)C=CC=C1F KSRSZVPLYYOTLU-UHFFFAOYSA-N 0.000 description 2
- QUVOLGJMWPXAAL-UHFFFAOYSA-N 5-(4-fluorophenyl)-1h-pyrazol-4-amine Chemical compound C1=NNC(C=2C=CC(F)=CC=2)=C1N QUVOLGJMWPXAAL-UHFFFAOYSA-N 0.000 description 2
- QHKIYTIYSBOAME-UHFFFAOYSA-N 5-(4-iodophenyl)-1h-pyrazol-4-amine Chemical compound NC1=CNN=C1C1=CC=C(I)C=C1 QHKIYTIYSBOAME-UHFFFAOYSA-N 0.000 description 2
- YLYPTGYHGCWJGN-UHFFFAOYSA-N 5-phenyl-1h-pyrazol-4-amine Chemical compound C1=NNC(C=2C=CC=CC=2)=C1N YLYPTGYHGCWJGN-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 240000001414 Eucalyptus viminalis Species 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 229910002666 PdCl2 Inorganic materials 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 2
- NYERCBJKHBDQGO-UHFFFAOYSA-N diphenyl(9h-xanthen-1-yl)phosphane Chemical compound C=12CC3=CC=CC=C3OC2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 NYERCBJKHBDQGO-UHFFFAOYSA-N 0.000 description 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- VYCKDIRCVDCQAE-UHFFFAOYSA-N isoquinolin-3-amine Chemical compound C1=CC=C2C=NC(N)=CC2=C1 VYCKDIRCVDCQAE-UHFFFAOYSA-N 0.000 description 2
- JGMSGABJHLXRRW-UHFFFAOYSA-N isoquinoline-7-carbonitrile Chemical compound C1=CN=CC2=CC(C#N)=CC=C21 JGMSGABJHLXRRW-UHFFFAOYSA-N 0.000 description 2
- RGGLAPZYXTXDGZ-UHFFFAOYSA-N isoquinoline-7-carboxamide Chemical compound C1=CN=CC2=CC(C(=O)N)=CC=C21 RGGLAPZYXTXDGZ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- IBSCADYIYSQTJC-UHFFFAOYSA-N methyl isoquinoline-7-carboxylate Chemical compound C1=CN=CC2=CC(C(=O)OC)=CC=C21 IBSCADYIYSQTJC-UHFFFAOYSA-N 0.000 description 2
- JFCHSQDLLFJHOA-UHFFFAOYSA-N n,n-dimethylsulfamoyl chloride Chemical compound CN(C)S(Cl)(=O)=O JFCHSQDLLFJHOA-UHFFFAOYSA-N 0.000 description 2
- CLXPVBYKMMVMFB-UHFFFAOYSA-N n-[1-(2,6-difluorobenzoyl)-5-(4-fluorophenyl)pyrazol-4-yl]-2,6-difluorobenzamide Chemical compound C1=CC(F)=CC=C1C(N(N=C1)C(=O)C=2C(=CC=CC=2F)F)=C1NC(=O)C1=C(F)C=CC=C1F CLXPVBYKMMVMFB-UHFFFAOYSA-N 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 239000012285 osmium tetroxide Substances 0.000 description 2
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 2
- RPGWZZNNEUHDAQ-UHFFFAOYSA-N phenylphosphine Chemical compound PC1=CC=CC=C1 RPGWZZNNEUHDAQ-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- DXNSNJONYUFURO-UHFFFAOYSA-N tert-butyl n-[1-(trifluoromethylsulfonyl)piperidin-4-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC1CCN(S(=O)(=O)C(F)(F)F)CC1 DXNSNJONYUFURO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- JZJWCDQGIPQBAO-UHFFFAOYSA-N 1-(4-iodophenyl)ethanone Chemical compound CC(=O)C1=CC=C(I)C=C1 JZJWCDQGIPQBAO-UHFFFAOYSA-N 0.000 description 1
- RRSCRODIPKBKPT-UHFFFAOYSA-N 1-(dimethylsulfamoyl)pyrazolo[4,3-c]isoquinoline-7-carboxylic acid Chemical compound CN(S(=O)(=O)N1N=CC=2N=CC=3C=C(C=CC=3C=21)C(=O)O)C RRSCRODIPKBKPT-UHFFFAOYSA-N 0.000 description 1
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 1
- AOYXWYFGLFWATH-UHFFFAOYSA-N 1-cyclopropylsulfonylpiperidin-4-amine Chemical compound C1CC(N)CCN1S(=O)(=O)C1CC1 AOYXWYFGLFWATH-UHFFFAOYSA-N 0.000 description 1
- JJWOMLRJNXMLSO-UHFFFAOYSA-N 1-methylsulfonylpiperidine Chemical compound CS(=O)(=O)N1CCCCC1 JJWOMLRJNXMLSO-UHFFFAOYSA-N 0.000 description 1
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
- KEZNMOUMHOZFRA-UHFFFAOYSA-N 1h-pyrazol-4-ylboronic acid Chemical compound OB(O)C=1C=NNC=1 KEZNMOUMHOZFRA-UHFFFAOYSA-N 0.000 description 1
- KEWAXFKLLZDCDX-UHFFFAOYSA-N 1h-pyrazolo[3,4-f]isoquinoline Chemical compound C1=CC2=CN=CC=C2C2=C1C=NN2 KEWAXFKLLZDCDX-UHFFFAOYSA-N 0.000 description 1
- UMHOTGGKIXUAGB-UHFFFAOYSA-N 1h-pyrazolo[4,3-c]isoquinoline-7-carboxylic acid Chemical compound N1=CC2=CC(C(=O)O)=CC=C2C2=C1C=NN2 UMHOTGGKIXUAGB-UHFFFAOYSA-N 0.000 description 1
- VWCXXNDPHWOUFJ-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;1-(trifluoromethylsulfonyl)piperidin-4-amine Chemical compound OC(=O)C(F)(F)F.NC1CCN(S(=O)(=O)C(F)(F)F)CC1 VWCXXNDPHWOUFJ-UHFFFAOYSA-N 0.000 description 1
- GPWNWKWQOLEVEQ-UHFFFAOYSA-N 2,4-diaminopyrimidine-5-carbaldehyde Chemical compound NC1=NC=C(C=O)C(N)=N1 GPWNWKWQOLEVEQ-UHFFFAOYSA-N 0.000 description 1
- VGNCEUZZZVRQMA-UHFFFAOYSA-N 2-[(7-ethenylpyrazolo[4,3-c]isoquinolin-2-yl)methoxy]ethyl-trimethylsilane Chemical compound C[Si](CCOCN1N=C2C(N=CC=3C=C(C=CC2=3)C=C)=C1)(C)C VGNCEUZZZVRQMA-UHFFFAOYSA-N 0.000 description 1
- CTKIHABGYIGASY-UHFFFAOYSA-N 2-[1-(dimethylamino)-3-(4-fluorophenyl)-3-oxoprop-1-en-2-yl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C(=CN(C)C)C(=O)C1=CC=C(F)C=C1 CTKIHABGYIGASY-UHFFFAOYSA-N 0.000 description 1
- JQFMNXFGEJQBBB-UHFFFAOYSA-N 2-[1-(dimethylamino)-3-(4-iodophenyl)-3-oxoprop-1-en-2-yl]isoindole-1,3-dione Chemical class O=C1C2=CC=CC=C2C(=O)N1C(=CN(C)C)C(=O)C1=CC=C(I)C=C1 JQFMNXFGEJQBBB-UHFFFAOYSA-N 0.000 description 1
- ZDVZXGKOLIOHEW-UHFFFAOYSA-N 2-[1-(dimethylamino)-3-oxo-3-phenylprop-1-en-2-yl]isoindole-1,3-dione Chemical class O=C1C2=CC=CC=C2C(=O)N1C(=CN(C)C)C(=O)C1=CC=CC=C1 ZDVZXGKOLIOHEW-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- RAFYYOBOJQUVIA-UHFFFAOYSA-N 2-[[3-bromo-5-(2,6-difluorophenyl)-7-(1h-pyrazol-4-yl)pyrazolo[4,3-c]isoquinolin-2-yl]methoxy]ethyl-trimethylsilane Chemical compound BrC=1N(COCC[Si](C)(C)C)N=C(C2=CC=C(C=C22)C3=CNN=C3)C=1N=C2C1=C(F)C=CC=C1F RAFYYOBOJQUVIA-UHFFFAOYSA-N 0.000 description 1
- FDZADIFQPLIFMF-UHFFFAOYSA-N 2-[[3-bromo-5-(2,6-difluorophenyl)-7-ethenylpyrazolo[4,3-c]isoquinolin-1-yl]methoxy]ethyl-trimethylsilane Chemical compound C=12C=C(C=C)C=CC2=C2N(COCC[Si](C)(C)C)N=C(Br)C2=NC=1C1=C(F)C=CC=C1F FDZADIFQPLIFMF-UHFFFAOYSA-N 0.000 description 1
- SDETWMXPMMYOHB-UHFFFAOYSA-N 2-[[3-bromo-5-(2,6-difluorophenyl)-7-fluoro-1,3-dihydropyrazolo[4,3-c]isoquinolin-2-yl]methoxy]ethyl-trimethylsilane Chemical compound BrC1N(COCC[Si](C)(C)C)NC(C2=CC=C(F)C=C22)=C1N=C2C1=C(F)C=CC=C1F SDETWMXPMMYOHB-UHFFFAOYSA-N 0.000 description 1
- VAYVGMJVQYMSCM-UHFFFAOYSA-N 2-[[3-bromo-5-(2,6-difluorophenyl)-7-iodopyrazolo[4,3-c]isoquinolin-1-yl]methoxy]ethyl-trimethylsilane Chemical compound C=12C=C(I)C=CC2=C2N(COCC[Si](C)(C)C)N=C(Br)C2=NC=1C1=C(F)C=CC=C1F VAYVGMJVQYMSCM-UHFFFAOYSA-N 0.000 description 1
- YYIKVPHFZFACGE-UHFFFAOYSA-N 2-[[3-bromo-5-(2,6-difluorophenyl)-7-iodopyrazolo[4,3-c]isoquinolin-2-yl]methoxy]ethyl-trimethylsilane Chemical compound BrC=1N(COCC[Si](C)(C)C)N=C(C2=CC=C(I)C=C22)C=1N=C2C1=C(F)C=CC=C1F YYIKVPHFZFACGE-UHFFFAOYSA-N 0.000 description 1
- ZJFWCELATJMDNO-UHFFFAOYSA-N 2-bromo-1-(4-fluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CBr)C=C1 ZJFWCELATJMDNO-UHFFFAOYSA-N 0.000 description 1
- NJJQFZCOSJYBII-UHFFFAOYSA-N 2-phenacylisoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(=O)C1=CC=CC=C1 NJJQFZCOSJYBII-UHFFFAOYSA-N 0.000 description 1
- DXWMPWWZDVHFQI-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound C=12C=C(C=O)C=CC2=C2N(COCC[Si](C)(C)C)N=C(Br)C2=NC=1C1=C(F)C=CC=C1F DXWMPWWZDVHFQI-UHFFFAOYSA-N 0.000 description 1
- RXOMYSPRJAEUPE-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-2-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound BrC=1N(COCC[Si](C)(C)C)N=C(C2=CC=C(C=O)C=C22)C=1N=C2C1=C(F)C=CC=C1F RXOMYSPRJAEUPE-UHFFFAOYSA-N 0.000 description 1
- QOEWKNXCTUUQSI-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-2-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound BrC=1N(COCC[Si](C)(C)C)N=C(C2=CC=C(C=C22)C#N)C=1N=C2C1=C(F)C=CC=C1F QOEWKNXCTUUQSI-UHFFFAOYSA-N 0.000 description 1
- FKLXVATYNSURCQ-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-2h-pyrazolo[4,3-c]isoquinoline Chemical compound FC1=CC=CC(F)=C1C(C1=CC=CC=C11)=NC2=C1NN=C2Br FKLXVATYNSURCQ-UHFFFAOYSA-N 0.000 description 1
- QWZQEEOABSXSBX-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-2h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound FC1=CC=CC(F)=C1C(C1=CC(=CC=C11)C#N)=NC2=C1NN=C2Br QWZQEEOABSXSBX-UHFFFAOYSA-N 0.000 description 1
- OVSVWCBZHSUWOK-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-7-fluoro-2h-pyrazolo[4,3-c]isoquinoline Chemical compound C12=CC(F)=CC=C2C=2NN=C(Br)C=2N=C1C1=C(F)C=CC=C1F OVSVWCBZHSUWOK-UHFFFAOYSA-N 0.000 description 1
- OSMFQEYOPOGRAA-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-7-iodo-2h-pyrazolo[4,3-c]isoquinoline Chemical compound FC1=CC=CC(F)=C1C(C1=CC(I)=CC=C11)=NC2=C1NN=C2Br OSMFQEYOPOGRAA-UHFFFAOYSA-N 0.000 description 1
- ZREYEONHFGJPJC-UHFFFAOYSA-N 3h-pyrazolo[3,4-c]isoquinoline Chemical compound C1=CC=C2C3=CNN=C3N=CC2=C1 ZREYEONHFGJPJC-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- LFWVHNUWSZWUMH-UHFFFAOYSA-N 4-aminopiperidine-1-sulfonamide Chemical compound NC1CCN(S(N)(=O)=O)CC1 LFWVHNUWSZWUMH-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
- YGBOCXKEAHYMRD-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-1-(dimethylsulfamoyl)pyrazolo[4,3-c]isoquinoline-7-carboxylic acid Chemical compound C=12C=C(C(O)=O)C=CC2=C2N(S(=O)(=O)N(C)C)N=CC2=NC=1C1=C(F)C=CC=C1F YGBOCXKEAHYMRD-UHFFFAOYSA-N 0.000 description 1
- SABYGKLRZUEAAD-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carboxylic acid Chemical compound C12=NC(C=3C(=CC=CC=3F)F)=C3C=C(C(O)=O)C=CC3=C2N(COCC[Si](C)(C)C)N=C1NC1CCN(S(C)(=O)=O)CC1 SABYGKLRZUEAAD-UHFFFAOYSA-N 0.000 description 1
- GOIKPIIRLOGEBZ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[[1-(trifluoromethylsulfonyl)piperidin-4-yl]amino]-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound C12=NC(C=3C(=CC=CC=3F)F)=C3C=C(C#N)C=CC3=C2N(COCC[Si](C)(C)C)N=C1NC1CCN(S(=O)(=O)C(F)(F)F)CC1 GOIKPIIRLOGEBZ-UHFFFAOYSA-N 0.000 description 1
- XIXNDWFABYBTTA-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-ethenyl-n-(1-methylsulfonylpiperidin-4-yl)-2-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(C)(=O)=O)CCC1NC=1N(COCC[Si](C)(C)C)N=C(C2=CC=C(C=C)C=C22)C=1N=C2C1=C(F)C=CC=C1F XIXNDWFABYBTTA-UHFFFAOYSA-N 0.000 description 1
- YEWINKXAUYADIJ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-fluoro-1h-pyrazolo[4,3-c]isoquinoline Chemical compound C12=CC(F)=CC=C2C=2NN=CC=2N=C1C1=C(F)C=CC=C1F YEWINKXAUYADIJ-UHFFFAOYSA-N 0.000 description 1
- AOEWOIBYSXBFJZ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-formyl-n,n-dimethylpyrazolo[4,3-c]isoquinoline-1-sulfonamide Chemical compound C=12C=C(C=O)C=CC2=C2N(S(=O)(=O)N(C)C)N=CC2=NC=1C1=C(F)C=CC=C1F AOEWOIBYSXBFJZ-UHFFFAOYSA-N 0.000 description 1
- NFVXWSLEZDTCRQ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-iodo-n,n-dimethylpyrazolo[4,3-c]isoquinoline-1-sulfonamide Chemical compound C=12C=C(I)C=CC2=C2N(S(=O)(=O)N(C)C)N=CC2=NC=1C1=C(F)C=CC=C1F NFVXWSLEZDTCRQ-UHFFFAOYSA-N 0.000 description 1
- NOOUKMFDRPQQGT-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-n-(1-ethylsulfonylpiperidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NN(COCC[Si](C)(C)C)C(C2=CC=CC=C22)=C1N=C2C1=C(F)C=CC=C1F NOOUKMFDRPQQGT-UHFFFAOYSA-N 0.000 description 1
- OKSDGTIDMUABFK-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-n-(1-methylsulfonylpiperidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C12=NC(C=3C(=CC=CC=3F)F)=C3C=CC=CC3=C2N(COCC[Si](C)(C)C)N=C1NC1CCN(S(C)(=O)=O)CC1 OKSDGTIDMUABFK-UHFFFAOYSA-N 0.000 description 1
- OTCUCFJGEVQMAD-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-n-(1-methylsulfonylpiperidin-4-yl)-7-(2h-triazol-4-yl)-2-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(C)(=O)=O)CCC1NC=1N(COCC[Si](C)(C)C)N=C(C2=CC=C(C=C22)C3=NNN=C3)C=1N=C2C1=C(F)C=CC=C1F OTCUCFJGEVQMAD-UHFFFAOYSA-N 0.000 description 1
- APKFPKLTEJAOJI-UHFFFAOYSA-N 6-butyldec-5-en-5-ylstannane Chemical compound CCCCC([SnH3])=C(CCCC)CCCC APKFPKLTEJAOJI-UHFFFAOYSA-N 0.000 description 1
- WDHJOCWEAQMTNZ-UHFFFAOYSA-N 6H-pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound N=1N=CC2=NC=C3CC(=CC=C3C21)C=O WDHJOCWEAQMTNZ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 238000006407 Bischler-Napieralski reaction Methods 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- SLLDBSPIQSXOQH-UHFFFAOYSA-N C[Si](C)(C)C#CC1=CC2=CN=C3C=NNC3=C2C=C1 Chemical compound C[Si](C)(C)C#CC1=CC2=CN=C3C=NNC3=C2C=C1 SLLDBSPIQSXOQH-UHFFFAOYSA-N 0.000 description 1
- VRMUSHDNRYPFLP-UHFFFAOYSA-N C[Si](C)(C)CCOCN1C2=C(C=N1)N=C(C3=C2C=CC(=C3)C#N)C4=C(C=CC=C4F)F Chemical compound C[Si](C)(C)CCOCN1C2=C(C=N1)N=C(C3=C2C=CC(=C3)C#N)C4=C(C=CC=C4F)F VRMUSHDNRYPFLP-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 1
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 description 1
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
- KXBTZGUVEQUYNP-UHFFFAOYSA-N N,N-dimethylpyrazolo[4,3-c]isoquinoline-1-sulfonamide Chemical compound CN(S(=O)(=O)N1N=CC=2N=CC=3C=CC=CC3C21)C KXBTZGUVEQUYNP-UHFFFAOYSA-N 0.000 description 1
- SAOLCSVVUPNUSP-UHFFFAOYSA-N N-(isoquinolin-7-ylmethylidene)hydroxylamine Chemical compound C1=NC=CC2=CC=C(C=C12)C=NO SAOLCSVVUPNUSP-UHFFFAOYSA-N 0.000 description 1
- OBTVWKOKSCAZPC-UHFFFAOYSA-N N-[[5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1-(2-trimethylsilylethoxymethyl)pyrazolo[4,3-c]isoquinolin-7-yl]methylidene]hydroxylamine Chemical compound C12=NC(C=3C(=CC=CC=3F)F)=C3C=C(C=NO)C=CC3=C2N(COCC[Si](C)(C)C)N=C1NC1CCN(S(C)(=O)=O)CC1 OBTVWKOKSCAZPC-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019213 POCl3 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 1
- 238000006619 Stille reaction Methods 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- UYJXRRSPUVSSMN-UHFFFAOYSA-P ammonium sulfide Chemical compound [NH4+].[NH4+].[S-2] UYJXRRSPUVSSMN-UHFFFAOYSA-P 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- XJHCXCQVJFPJIK-UHFFFAOYSA-M cesium fluoride Substances [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 238000007333 cyanation reaction Methods 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- IMDXZWRLUZPMDH-UHFFFAOYSA-N dichlorophenylphosphine Chemical compound ClP(Cl)C1=CC=CC=C1 IMDXZWRLUZPMDH-UHFFFAOYSA-N 0.000 description 1
- 125000006333 difluoro benzoyl group Chemical group 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000003682 fluorination reaction Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000001033 granulometry Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- RFYKMRGOPAKUHD-UHFFFAOYSA-N isoquinoline-7-carboximidamide Chemical compound C1=CN=CC2=CC(C(=N)N)=CC=C21 RFYKMRGOPAKUHD-UHFFFAOYSA-N 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- BPPAQDYMIMQAEF-UHFFFAOYSA-N methyl 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carboxylate Chemical compound C1=2N=C(C=3C(=CC=CC=3F)F)C3=CC(C(=O)OC)=CC=C3C=2NN=C1NC1CCN(S(C)(=O)=O)CC1 BPPAQDYMIMQAEF-UHFFFAOYSA-N 0.000 description 1
- PRMMOGVAULUEQJ-UHFFFAOYSA-N n-[1-(2,6-difluorobenzoyl)-5-(4-iodophenyl)pyrazol-4-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=C(C=2C=CC(I)=CC=2)N(C(=O)C=2C(=CC=CC=2F)F)N=C1 PRMMOGVAULUEQJ-UHFFFAOYSA-N 0.000 description 1
- PNQBYFZJSASWNL-UHFFFAOYSA-N n-[1-(2,6-difluorobenzoyl)-5-phenylpyrazol-4-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=C(C=2C=CC=CC=2)N(C(=O)C=2C(=CC=CC=2F)F)N=C1 PNQBYFZJSASWNL-UHFFFAOYSA-N 0.000 description 1
- NAEICDPYHCEZMG-UHFFFAOYSA-N n-piperidin-4-ylmethanesulfonamide Chemical compound CS(=O)(=O)NC1CCNCC1 NAEICDPYHCEZMG-UHFFFAOYSA-N 0.000 description 1
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 150000002825 nitriles Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012011 nucleophilic catalyst Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 150000002923 oximes Chemical group 0.000 description 1
- 150000002940 palladium Chemical class 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- IMACFCSSMIZSPP-UHFFFAOYSA-N phenacyl chloride Chemical compound ClCC(=O)C1=CC=CC=C1 IMACFCSSMIZSPP-UHFFFAOYSA-N 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- COEZWFYORILMOM-UHFFFAOYSA-M sodium 4-[(2,4-dihydroxyphenyl)diazenyl]benzenesulfonate Chemical compound [Na+].OC1=CC(O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 COEZWFYORILMOM-UHFFFAOYSA-M 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 229940071182 stannate Drugs 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Natural products CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 1
- LZRDHSFPLUWYAX-UHFFFAOYSA-N tert-butyl 4-aminopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(N)CC1 LZRDHSFPLUWYAX-UHFFFAOYSA-N 0.000 description 1
- CKXZPVPIDOJLLM-UHFFFAOYSA-N tert-butyl n-piperidin-4-ylcarbamate Chemical compound CC(C)(C)OC(=O)NC1CCNCC1 CKXZPVPIDOJLLM-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- GRGCWBWNLSTIEN-UHFFFAOYSA-N trifluoromethanesulfonyl chloride Chemical compound FC(F)(F)S(Cl)(=O)=O GRGCWBWNLSTIEN-UHFFFAOYSA-N 0.000 description 1
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical compound C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0901995A FR2944792B1 (fr) | 2009-04-24 | 2009-04-24 | Derives de 1h-pyrazolo[4,3-c]isoquinoleines, leur preparation et leur application en therapeutique |
| FR0901995 | 2009-04-24 | ||
| PCT/FR2010/050773 WO2010122272A1 (fr) | 2009-04-24 | 2010-04-22 | DERIVES DE 1-PYRAZOLO[4,3-c]ISOQUINOLEINES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2515240T3 true ES2515240T3 (es) | 2014-10-29 |
Family
ID=41259738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10723723.2T Active ES2515240T3 (es) | 2009-04-24 | 2010-04-22 | Derivados de 1H-pirazolo[4,3-c]isoquinoleínas, su preparación y su aplicación en terapéutica |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8461175B2 (enExample) |
| EP (1) | EP2421864B1 (enExample) |
| JP (1) | JP5722880B2 (enExample) |
| KR (1) | KR101675609B1 (enExample) |
| CN (1) | CN102459260B (enExample) |
| AR (1) | AR076393A1 (enExample) |
| AU (1) | AU2010240742B2 (enExample) |
| BR (1) | BRPI1013724A2 (enExample) |
| CA (1) | CA2791947A1 (enExample) |
| CY (1) | CY1115678T1 (enExample) |
| DK (1) | DK2421864T3 (enExample) |
| ES (1) | ES2515240T3 (enExample) |
| FR (1) | FR2944792B1 (enExample) |
| HR (1) | HRP20141058T1 (enExample) |
| IL (1) | IL215733A (enExample) |
| MX (1) | MX2011011246A (enExample) |
| MY (1) | MY156362A (enExample) |
| PL (1) | PL2421864T3 (enExample) |
| PT (1) | PT2421864E (enExample) |
| RU (1) | RU2530775C2 (enExample) |
| SG (1) | SG175338A1 (enExample) |
| SI (1) | SI2421864T1 (enExample) |
| TW (1) | TWI468405B (enExample) |
| UY (1) | UY32575A (enExample) |
| WO (1) | WO2010122272A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109020972B (zh) * | 2018-10-08 | 2021-03-09 | 广东石油化工学院 | 一种三唑并[1，5-a]喹啉衍生物的制备方法 |
| WO2023039510A1 (en) * | 2021-09-10 | 2023-03-16 | The Trustees Of Columbia University In The City Of New York | Gpx4 inhibitors and uses thereof |
| CN116535356A (zh) * | 2023-03-06 | 2023-08-04 | 中国药科大学 | 3-氨基-5-苯基-吡唑类衍生物微管蛋白抑制剂及其制备和医药用途 |
| EP4506003A1 (en) | 2023-08-07 | 2025-02-12 | S.Yu Yunusov Institute of Chemistry of Plant Substances of the Academy of Sciences of the Republic of Uzbekistan | Halogen derivatives of (4´,5´- methylenedioxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline for use in the treatment of leukemia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8600752D0 (en) * | 1986-01-14 | 1986-02-19 | Roussel Lab Ltd | Chemical compounds |
| DE10229762A1 (de) * | 2002-07-03 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase |
| US7132428B2 (en) * | 2003-07-03 | 2006-11-07 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders |
| CA2531291A1 (en) * | 2003-07-03 | 2005-02-10 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivatives as kinase inhibitors |
| AU2004259012C1 (en) * | 2003-07-23 | 2012-08-02 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
| AR058223A1 (es) * | 2005-11-25 | 2008-01-23 | Palau Pharma Sa | Un comuesto de derivados de pirazoloisoquinolina, un procedimiento para l a preparacion de dicho compuesto y una composicion farmaceutica que comprende dicho compuesto |
-
2009
- 2009-04-24 FR FR0901995A patent/FR2944792B1/fr not_active Expired - Fee Related
-
2010
- 2010-04-22 CA CA2791947A patent/CA2791947A1/fr not_active Abandoned
- 2010-04-22 SI SI201030757T patent/SI2421864T1/sl unknown
- 2010-04-22 MY MYPI2011005108A patent/MY156362A/en unknown
- 2010-04-22 ES ES10723723.2T patent/ES2515240T3/es active Active
- 2010-04-22 HR HRP20141058AT patent/HRP20141058T1/hr unknown
- 2010-04-22 US US13/265,981 patent/US8461175B2/en not_active Expired - Fee Related
- 2010-04-22 BR BRPI1013724A patent/BRPI1013724A2/pt not_active IP Right Cessation
- 2010-04-22 SG SG2011077963A patent/SG175338A1/en unknown
- 2010-04-22 EP EP10723723.2A patent/EP2421864B1/fr active Active
- 2010-04-22 CN CN201080028355.1A patent/CN102459260B/zh not_active Expired - Fee Related
- 2010-04-22 MX MX2011011246A patent/MX2011011246A/es active IP Right Grant
- 2010-04-22 PT PT107237232T patent/PT2421864E/pt unknown
- 2010-04-22 PL PL10723723T patent/PL2421864T3/pl unknown
- 2010-04-22 KR KR1020117027900A patent/KR101675609B1/ko not_active Expired - Fee Related
- 2010-04-22 AU AU2010240742A patent/AU2010240742B2/en not_active Ceased
- 2010-04-22 JP JP2012506551A patent/JP5722880B2/ja not_active Expired - Fee Related
- 2010-04-22 DK DK10723723.2T patent/DK2421864T3/da active
- 2010-04-22 RU RU2011147658/04A patent/RU2530775C2/ru not_active IP Right Cessation
- 2010-04-22 WO PCT/FR2010/050773 patent/WO2010122272A1/fr not_active Ceased
- 2010-04-23 UY UY0001032575A patent/UY32575A/es not_active Application Discontinuation
- 2010-04-23 TW TW99112914A patent/TWI468405B/zh not_active IP Right Cessation
- 2010-04-23 AR ARP100101357A patent/AR076393A1/es unknown
-
2011
- 2011-10-11 IL IL215733A patent/IL215733A/en not_active IP Right Cessation
-
2014
- 2014-10-30 CY CY20141100897T patent/CY1115678T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113527293B (zh) | Kras g12c突变蛋白抑制剂及其药物组合物、制备方法和用途 | |
| CN108699077B (zh) | 作为rsv抑制剂的杂环化合物 | |
| EP1140941B1 (en) | Nitrogen containing heterobicycles as factor xa inhibitors | |
| ES2708998T3 (es) | Carboxamidas primarias como inhibidores de btk | |
| ES2623387T3 (es) | Nuevos compuestos de piridina condensada como inhibidores de la cinasa de caseína | |
| PH12015501004B1 (en) | AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHa RESPONSES | |
| WO2013148603A1 (en) | Cinnoline derivatives as as btk inhibitors | |
| WO2011146287A1 (en) | Pyrazolo[4,3-b]pyridine-7-amine inhibitors of alk5 | |
| WO2015195880A1 (en) | Imidazo-pyridazne derivatives as casein kinase 1 delta/epsilon inhibitors | |
| KR20160086930A (ko) | 피롤로피롤론 유도체 및 bet 억제제로서의 그의 용도 | |
| CN111320624A (zh) | 三唑并吡啶类和咪唑并吡啶类化合物及其制备方法和医药用途 | |
| CN104837844A (zh) | 作为酪蛋白激酶1 d/e抑制剂的吡唑取代的咪唑并哌嗪 | |
| AU2004295309A1 (en) | Diazaindole-dicarbonyl-piperazinyl antiviral agents | |
| CN102076686A (zh) | 作为hiv附着抑制剂的二酮哌啶衍生物 | |
| ES2515240T3 (es) | Derivados de 1H-pirazolo[4,3-c]isoquinoleínas, su preparación y su aplicación en terapéutica | |
| ES2304546T3 (es) | Derivados de priridoindolona sustituidos en la posicion 3 con un fenilo, su preparacion y su aplicacion en terapeutica. | |
| JP7077323B2 (ja) | キナゾリン化合物並びにその調製方法、使用及び医薬組成物 | |
| ES2303776B1 (es) | Derivados de 5-fenil-6-piridin-4-il-1,3-dihidro-2h-imidazo(4,5-b)piridin-2-ona utiles como antagonistas del receptor de adenosina a2b. | |
| AU2020266604A1 (en) | Modulators of TREX1 | |
| CN113412112A (zh) | 作为c-MET抑制剂的有机磷取代化合物及其治疗用途 | |
| JP2025526717A (ja) | ＴＧＦ－β阻害剤化合物及びその使用 | |
| CN116669769A (zh) | Helios的哌啶基小分子降解剂和使用方法 | |
| HK1167387B (en) | 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof |